BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8352554)

  • 1. The expression of genes of the steroid-thyroid hormone receptor superfamily in central nervous system tumors.
    Magrassi L; Butti G; Silini E; Bono F; Paoletti P; Milanesi G
    Anticancer Res; 1993; 13(4):859-66. PubMed ID: 8352554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms.
    Berkman RA; Merrill MJ; Reinhold WC; Monacci WT; Saxena A; Clark WC; Robertson JT; Ali IU; Oldfield EH
    J Clin Invest; 1993 Jan; 91(1):153-9. PubMed ID: 8380810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D receptor expression in human brain tumors.
    Magrassi L; Bono F; Milanesi G; Butti G
    J Neurosurg Sci; 1992; 36(1):27-30. PubMed ID: 1323646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of thyroid hormone receptor isoforms in human astrocytomas.
    Hwang SL; Lin CL; Lieu AS; Hwang YF; Howng SL; Hong YR; Chang DS; Lee KS
    Surg Neurol; 2008 Dec; 70 Suppl 1():S1:4-8; discussion S1:8. PubMed ID: 18617237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen and progesterone receptors in meningiomas and gliomas.
    Georgakulias N; Singounas E; Kypriades E; Giotis J; Karvounis P
    Zentralbl Neurochir; 1993; 54(3):139-42. PubMed ID: 8237168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gonadotropin-releasing hormone (GnRH) and its receptor in human meningiomas.
    Hirota Y; Tachibana O; Uchiyama N; Hayashi Y; Nakada M; Kita D; Watanabe T; Higashi R; Hamada J; Hayashi Y
    Clin Neurol Neurosurg; 2009 Feb; 111(2):127-33. PubMed ID: 18980792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Bcl2 proto-oncogene in primary tumors of the central nervous system.
    Tyagi D; Sharma BS; Gupta SK; Kaul D; Vasishta RK; Khosla VK
    Neurol India; 2002 Sep; 50(3):290-4. PubMed ID: 12391455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of thyroid hormone receptors in intracranial meningiomas.
    Wang CJ; Lin PC; Howng SL
    Kaohsiung J Med Sci; 2003 Jul; 19(7):334-8. PubMed ID: 12926518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of RNA expression for cholecystokinin/gastrin receptors (CCKA, CCKB and CCKC) in human tumors of the central and peripheral nervous system.
    Lefranc F; Chaboteaux C; Belot N; Brotchi J; Salmon I; Kiss R
    Int J Oncol; 2003 Jan; 22(1):213-9. PubMed ID: 12469207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HuR, a RNA stability factor, is expressed in malignant brain tumors and binds to adenine- and uridine-rich elements within the 3' untranslated regions of cytokine and angiogenic factor mRNAs.
    Nabors LB; Gillespie GY; Harkins L; King PH
    Cancer Res; 2001 Mar; 61(5):2154-61. PubMed ID: 11280780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Steroid receptors in the central nervous system. Implications in neurology].
    Poisson M; Pertuiset BF; Moguilewsky M; Magdelenat H; Martin PM
    Rev Neurol (Paris); 1984; 140(4):233-48. PubMed ID: 6371995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SP100 reduces malignancy of human glioma cells.
    Held-Feindt J; Hattermann K; Knerlich-Lukoschus F; Mehdorn HM; Mentlein R
    Int J Oncol; 2011 Apr; 38(4):1023-30. PubMed ID: 21274506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bcl2 and ROS1 expression in human meningiomas: an analysis with respect to histological subtype.
    Girish V; Sachdeva N; Minz RW; Radotra B; Mathuria SN; Arora SK
    Indian J Pathol Microbiol; 2005 Jul; 48(3):325-30. PubMed ID: 16761743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and structure of interleukin 4 receptors in primary meningeal tumors.
    Puri S; Joshi BH; Sarkar C; Mahapatra AK; Hussain E; Sinha S
    Cancer; 2005 May; 103(10):2132-42. PubMed ID: 15830341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invariant Valpha7.2-Jalpha33 TCR is expressed in human kidney and brain tumors indicating infiltration by mucosal-associated invariant T (MAIT) cells.
    Peterfalvi A; Gomori E; Magyarlaki T; Pal J; Banati M; Javorhazy A; Szekeres-Bartho J; Szereday L; Illes Z
    Int Immunol; 2008 Dec; 20(12):1517-25. PubMed ID: 18927318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of somatostatin messenger RNA and receptor in cultured brain tumor cells.
    Hirota N; Matsumoto K; Iida M; Sakagami H; Takeda M
    Anticancer Res; 1998; 18(5A):3295-7. PubMed ID: 9858898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraoxonase 192 gene polymorphism and serum paraoxonase activity in high grade gliomas and meningiomas.
    Kafadar AM; Ergen A; Zeybek U; Agachan B; Kuday C; Isbir T
    Cell Biochem Funct; 2006; 24(5):455-60. PubMed ID: 16142697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spreading and migration of human glioma and rat C6 cells on central nervous system myelin in vitro is correlated with tumor malignancy and involves a metalloproteolytic activity.
    Amberger VR; Hensel T; Ogata N; Schwab ME
    Cancer Res; 1998 Jan; 58(1):149-58. PubMed ID: 9426071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis.
    Ljubimova JY; Lakhter AJ; Loksh A; Yong WH; Riedinger MS; Miner JH; Sorokin LM; Ljubimov AV; Black KL
    Cancer Res; 2001 Jul; 61(14):5601-10. PubMed ID: 11454714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YY1 Over-expression in human brain gliomas and meningiomas correlates with TGF-beta1, IGF-1 and FGF-2 mRNA levels.
    Baritaki S; Chatzinikola AM; Vakis AF; Soulitzis N; Karabetsos DA; Neonakis I; Bonavida B; Spandidos DA
    Cancer Invest; 2009 Feb; 27(2):184-92. PubMed ID: 19235591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.